|Bid||78.61 x 100|
|Ask||79.18 x 100|
|Day's Range||78.87 - 79.78|
|52 Week Range||69.30 - 98.44|
|PE Ratio (TTM)||16.45|
|Dividend & Yield||2.00 (2.52%)|
|1y Target Est||N/A|
Instant Pickup’s real targets in the long-term aren’t the 7-11s and Wawas of the world but rather pharmacies like Walgreens and CVS.
For several reasons, Rite Aid now has the right prescription to heal the tough wounds investors have suffered over the past several years. The company’s valuation, currently at $2.4 billion, is a fraction of the $8.5 billion it was valued at in January when it had an offer on the table from Walgreens of $6.50 to $7.00 per share. This is even though both Rite Aid and Walgreens agreed to divest several stores to Fred’s, Inc. (NASDAQ:FRED) to make the deal more palatable.
ST. LOUIS (AP) — The nation's largest pharmacy benefit manager will soon limit the number and strength of opioid drugs prescribed to first-time users as part of a wide-ranging effort to curb an epidemic affecting millions of Americans.